Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lim

Showing results (881-890 of 926) with videos related to

Pageof 93
Sort By:
Physical Review Letters|November 20, 2020
Search for Sub-eV Sterile Neutrinos at RENOJ H Choi, H I Jang, J S Jang, et al.
Leukemia|February 14, 2018
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphomaM -L Nairismägi, M E Gerritsen, Z M Li, et al.
Nature Neuroscience|July 18, 2017
Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorderElaine T Lim, Mohammed Uddin, Silvia De Rubeis, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanomaElena Garralda, Christoph Markert, Victor Moreno, et al.
Physical Review Letters|July 13, 2019
Fuel-Composition Dependent Reactor Antineutrino Yield at RENOG Bak, J H Choi, H I Jang, et al.
Physical Review Letters|June 11, 2016
Observation of Energy and Baseline Dependent Reactor Antineutrino Disappearance in the RENO ExperimentJ H Choi, W Q Choi, Y Choi, et al.
Physical Review Letters|December 1, 2018
Measurement of Reactor Antineutrino Oscillation Amplitude and Frequency at RENOG Bak, J H Choi, H I Jang, et al.
Physical Review Letters|September 26, 2012
Observation of reactor electron antineutrinos disappearance in the RENO experimentJ K Ahn, S Chebotaryov, J H Choi, et al.
Gynecologic Oncology|July 1, 2026
Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancerMark S Shahin, Domenica Lorusso, Floor J Backes, et al.
Pageof 93

Showing results (881-890 of 926) with videos related to

Sort By:
Pageof 93
Physical Review Letters|November 20, 2020
Search for Sub-eV Sterile Neutrinos at RENOJ H Choi, H I Jang, J S Jang, et al.
Leukemia|February 14, 2018
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphomaM -L Nairismägi, M E Gerritsen, Z M Li, et al.
Nature Neuroscience|July 18, 2017
Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorderElaine T Lim, Mohammed Uddin, Silvia De Rubeis, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanomaElena Garralda, Christoph Markert, Victor Moreno, et al.
Physical Review Letters|July 13, 2019
Fuel-Composition Dependent Reactor Antineutrino Yield at RENOG Bak, J H Choi, H I Jang, et al.
Physical Review Letters|June 11, 2016
Observation of Energy and Baseline Dependent Reactor Antineutrino Disappearance in the RENO ExperimentJ H Choi, W Q Choi, Y Choi, et al.
Physical Review Letters|December 1, 2018
Measurement of Reactor Antineutrino Oscillation Amplitude and Frequency at RENOG Bak, J H Choi, H I Jang, et al.
Physical Review Letters|September 26, 2012
Observation of reactor electron antineutrinos disappearance in the RENO experimentJ K Ahn, S Chebotaryov, J H Choi, et al.
Gynecologic Oncology|July 1, 2026
Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancerMark S Shahin, Domenica Lorusso, Floor J Backes, et al.
Pageof 93